In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The number of functionally active synapses provides a measure of neural integrity, with reductions observed in neurodegenerative disorders. [11C]UCB-J binds to synaptic vesicle 2A (SV2A) transmembrane protein located in secretory vesicles. We aimed to assess [11C]UCB-J PET as an in vivo biomarker of regional cerebral synaptic SV2A density in rat lesion models of neurodegeneration. Healthy anesthetized rats had [11C]UCB-J PET and arterial blood sampling. We compared different models describing [11C]UCB-J brain uptake kinetics to determine its regional distribution. Blocking studies were performed with levetiracetam (LEV), an antiepileptic SV2A antagonist. Tracer binding was measured in rodent unilateral acute lesion models of Parkinsonism and Huntington’s disease, induced with 6-hydroxydopamine (6-OHDA) and quinolinic acid (QA), respectively. [3H]UCB-J autoradiography was performed in postmortem tissue. Rat brain showed high and fast [11C]UCB-J uptake and washout with up to 80% blockade by LEV. [11C]UCB-J PET showed a 6.2% decrease in ipsilateral striatal SV2A binding after 6-OHDA and 39.3% and 55.1% decreases after moderate and high dose QA confirmed by autoradiography. In conclusion, [11C]UCB-J PET provides a good in vivo marker of synaptic SV2A density which can potentially be followed longitudinally along with synaptic responses to putative neuroprotective agents in models of neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other SV2A-PET studies have shown significantly lower SV2A density in rodent models Parkinson's and Huntington's disease [148-151].”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [150]
Citations
Cites
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286 · cited 1×
“This sparing of somatostatin and neuropeptide Y positive medium spiny neurons in the striatum alongside striking GABA spiny neuronal cell death resembles the pathology of Huntington’s disease.(30) In our experiment, we saw a significant effect of QA toxicity on striatal SV2A binding.”
BackgroundImaging synaptic density in the living human brain
Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575 · cited 1×
“A unilateral reduction of [11C] UCB-J binding was found at the seizure onset zone in the hippocampus of 3 patients with temporal lobe epilepsy.(8) In 10 Alzheimer’s disease patients, a significant reduction in hippocampal [11C]UCB-J binding was seen compared to 11 cognitively healthy controls.”
Lower synaptic density is associated with depression severity and network alterations
Holmes, S. E., Scheinost, D., Finnema, S. J., Naganawa, M., Davis, M. T., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Pietrzak, R. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09562-7 · Cited by 484 · cited 1×
“In individuals with severe depression, reduced [11C]UCB-J binding targeted the dorsolateral prefrontal cortex, anterior cingulate cortex and hippocampus.(15) Rodents are routinely used as models of neurodegenerative and inflammatory disease, to study mechanisms of drug addiction, basic brain functions, and to test tar…”
BackgroundDifferential expression of synaptic vesicle protein 2 (SV2) isoforms
Bajjalieh, S., Frantz, G., Weimann, J., McConnell, S., & Scheller, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05223.1994 · Cited by 440 · cited 1×
“The recently developed PET tracer [11C]UCB-J binds to the synaptic vesicle glycoprotein 2A (SV2A), a transmembrane protein expressed ubiquitously and located in presynaptic vesicles throughout the brain.(4,5) SV2A plays an important role in synaptic (1)Department of Nuclear Medicine and PET Center, Department of”
BackgroundChen, M.-K., Mecca, A. P., Naganawa, M., Finnema, S. J., Toyonaga, T., Lin, S.-F., Najafzadeh, S., Ropchan, J., Lu, Y., McDonald, J. W., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1836 · Cited by 431
Quinolinic acid: an endogenous neurotoxin with multiple targets
Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104024 · Cited by 394 · cited 2×
“QA exerts neurotoxicity by increasing Ca flux into neurons via the NMDAion channels, disturbing the cytoskeleton, generating free radicals and oxidative stress and by causing lipid peroxidation.(29) Chronic exposure can cause structural changes affecting the microtubullar distribution and a decrease in organelles.”
BackgroundMechanism of 6-hydroxydopamine neurotoxicity
Glinka, Y., Gassen, M., & Youdim, M. B. H. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_7 · Cited by 380
Comparative evaluation of synaptophysin-based methods for quantification of synapses
Calhoun, M. E., Jucker, M., Martin, L. J., Thinakaran, G., Price, D. L., & Mouton, P. R. (1996) · Journal of Neurocytology · doi:10.1007/bf02284844 · Cited by 302 · cited 1×
“Earlier studies of synaptic density have relied on postmortem methods where biopsies were used to quantify the synapses using synaptophysin histology, electron microscopy or Western blotting.(6) The use of [11C]UCB-J PET allows the in vivo study of synaptic SV2A density in living individuals that can be applied when d…”
MethodNabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296 · cited 3×
“[11C]UCB-J microPET imaging The [11C]UCB-J tracer was produced using a modification of the method reported by Nabulsi et al.4 For pilot studies, precursor was provided by UCB Pharma (Belgium).”
BackgroundMethodSynaptic Dysfunction in Parkinson’s Disease
Picconi, B., Piccoli, G., & Calabresi, P. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_24 · Cited by 290
Research works printed but not linked: 2
- Bertoglio D, 2019, J Cereb Blood Flow Metab, ■
- Shiozaki T, 2000, J Nucl Med, 41, 1612
Cited by
Radiopharmaceuticals and their applications in medicine
Zhang, S., Wang, X., Gao, X., Chen, X., Li, L., Li, G., Liu, C., Miao, Y., Wang, R., & Hu, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02041-6 · Cited by 284
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123
Self-citationImaging of Synaptic Density in Neurodegenerative Disorders
Carson, R. E., Naganawa, M., Toyonaga, T., Koohsari, S., Yang, Y., Chen, M.-K., Matuskey, D., & Finnema, S. J. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263201 · Cited by 104
“Rat PD lesion 6-OHDA (20mg) local injection in striatum 3 SUV 6% (striatum) (51)”
BackgroundInfluentialImaging Synaptic Density: The Next Holy Grail of Neuroscience?
Serrano, M. E., Kim, E., Petrinovic, M. M., Turkheimer, F., & Cash, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.796129 · Cited by 67
“…changes in synaptic density in the 6-hydroxydopamine (6-OHDA) model of Parkinson’s disease and the quinolinic acid model of Huntington’s disease (Thomsen et al., 2021), and to study the effect of different drugs and treatments (Onwordi et al., 2020; Binda et al., 2021; Halff et al., 2021;…”
BackgroundThomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M., & Romero-Ramos, M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105229 · Cited by 62
Self-citation
Metadata
- Authors
- Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M.
- Affiliations
- Aarhus University (DK)
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- Corresponding author
- Landau, Anne M
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2020-06-14
- Volume
- 41
- Issue
- 4
- Pages
- 819-830
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC7983510
- OpenAlex
- W3033668013
- Cited by
- 38
- References
- 30
- Citations by year
- 2025: 5 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 3
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Aarhus Universitet
- Aarhus Universitetshospital
- Parkinsonforeningen
- Lundbeckfonden (R165-2013-16034, R218-2016-1486)
- H. Lundbeck A/S
- UCB Pharma
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- [11C]UCB-J, striatal lesions, neurodegeneration, parkinsonism, Huntington's disease, 6-hydroxydopamine, quinolinic acid, levetiracetam, positron emission tomography
- MeSH terms
- Levetiracetam, Animals, Anticonvulsants, Autoradiography, Corpus Striatum, Female, Huntington Disease, Hydroxydopamines, Kinetics, Membrane Glycoproteins, Nerve Tissue Proteins, Parkinson Disease, Secondary, Synapses, Rats, Sprague-Dawley, Quinolinic Acid, Neuroprotective Agents, Radiopharmaceuticals, Positron-Emission Tomography, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. https://app.cochat.ai/papers/10.1177/0271678x20931140
- The paper
- Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M. (2021). In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x20931140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.